Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it's Q1 report. Some of it's shortfall was attributed by management to longer sales cycles in the insurer and employer space

3 Healthcare Stocks That Are Too Cheap to Ignore

06:00am, Wednesday, 11'th May 2022
A rebound could be on the horizon.
Here's why this deal makes sense.

Teladoc: My Bullish Thesis

01:11am, Tuesday, 10'th May 2022
In this article, I explain my bullish thesis for Teladoc and Telemedicine. Teladoc's Q1'22 earnings weren't particularly impressive, but it's still too early to call it quits.
Teladoc Health's (TDOC) bet on mental health service BetterHelp is likely to generate lower yield this year.
First-quarter revenue miss reset Teladoc's prospects for shareholders, pressuring the company to accelerate its multi-product launch. The post Investors Should Take a Bigger Position When Teledoc Post

Teladoc Health: Following Cathie Wood For Once

08:30am, Sunday, 08'th May 2022
Teladoc Health collapsed following weak guidance for 2022. Cathie Wood loaded up on the dip buying 600K shares on April 28.

3 Bargain Stocks Cathie Wood Loves

06:05am, Sunday, 08'th May 2022
Investors can take advantage of the tech sell-off by purchasing these three growth stocks at a discount.
Buying the dip in top growth stocks or when they're on the verge of exploding is a proven way to build wealth.
Teladoc has been caught up in the wave as the tech sector has sunk. But it's getting increasingly hard to dismiss TDOC stock's specific flaws, as well.

The Real Reason Teladoc Is Struggling

06:15am, Thursday, 05'th May 2022
A case of unfulfilled promises.

Teladoc: Revisiting My Thesis

11:48am, Wednesday, 04'th May 2022
The negative outlook for TDOC is exaggerated, and the market sees the glass as half empty even though the revised full-year 2022 revenue guidance is not bad. Additional impairment downside is possible

Teladoc: Cracks Widen, But Thesis Is Not Broken

09:30am, Wednesday, 04'th May 2022
Teladoc's Q1 results were weak, but management's 2022 guidance cut and the goodwill impairment expense of $6.6B were simply horrific developments at the company. While the Livongo acquisition has turn

Why Teladoc's Q1 Results Really Weren't That Bad

09:15am, Wednesday, 04'th May 2022
The stock's sell-off was an extreme reaction to its earnings report. A rally this year could follow.
That large a portfolio might be overwhelming for some investors, but it's anxiety-reducing for me.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE